- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
The primary objective is to demonstrate that a prophylaxis regimen of BeneFIX reduces the ABR compared to on demand treatment in subjects with moderately severe to severe hemophilia B.
Critère d'inclusion
- Hemophilia B